Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Altamira Therapeutics Ltd
(NQ:
CYTO
)
1.690
+0.090 (+5.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
166,284
Open
1.540
Bid (Size)
1.650 (3)
Ask (Size)
1.720 (2)
Prev. Close
1.600
Today's Range
1.495 - 1.770
52wk Range
0.0940 - 5.790
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
April 24, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 22, 2024
Via
Benzinga
Performance
YTD
-51.16%
-51.16%
1 Month
-28.09%
-28.09%
3 Month
-15.50%
-15.50%
6 Month
+908.35%
+908.35%
1 Year
+64.08%
+64.08%
More News
Read More
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
April 10, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Earnings Scheduled For April 10, 2024
April 10, 2024
Via
Benzinga
CYTO Stock Earnings: Altamira Therapeutics Reported Results for H1 2023
December 14, 2023
Via
InvestorPlace
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
April 04, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Nasdaq Turns Higher; Akanda Shares Plunge
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
March 25, 2024
Via
Benzinga
Crude Oil Moves Higher; US New Home Sales Fall In February
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
Why Altamira Therapeutics Stock Is Racing Higher
March 25, 2024
Via
Benzinga
US Stocks Down; Chicago Fed National Activity Index Rises In February
March 25, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
March 25, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
March 01, 2024
Via
Benzinga
Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal
February 07, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
January 24, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 11, 2024
Via
InvestorPlace
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
January 08, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 29, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
December 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Via
InvestorPlace
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 11, 2023
Via
Benzinga
Why Altamira Therapeutics (CYTO) Stock Is Down 50% Today
December 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.